欢迎您访问武汉艾美捷科技有限公司官方网站!
站点地图 服务热线:400-6800-868
  • 产品
  • 文章

PRODUCT CENTER

ELISA试剂盒
产品中心

当前位置:首页 > 产品中心 > 免疫学产品 > ELISA试剂盒

中文名称

包柔氏螺旋体菌IgM Elisa试剂盒

英文名字
Borrelien IgM ELISA Kit
供应商
Biomedica Immunoassays
产品货号
BI-21042
产品报价
¥12x8tests
产品说明书
点击查看
购买方式
90%产品中国有现货库存。银行转账、电汇、支票、现金,在线支付宝及网银支付,或直接与我们电话联系400-6800-868
产品新闻
背景资料
Lyme borreliosis is a bacterial infection caused by the spirochete Borrelia Burgdorferi, Borrelia Afzelii and Borrelia Garinii and is the most vector-transmitted human disease in Europe. The spirochetal bacteria were first described and isolated in 1981 by Willi Burgdorfer in the tick Ixodes dammini in Montana (USA). The infection with Borrelia is characterized by a variety of clinical symptoms and can be divided into 3 stages:

Stage 1, early dermatitis, appearing days or weeks after the infection. Clinical: erythema migrans.
Stage 2, early disseminated infection, appears weeks to months after infection. Clinical: lymphocytic meningoradiculitis (Bannwarth's syndrome), neuroborreliosis.
Stage 3, late disseminated infection, occurring up to years after infection. Clinical: chronic progressive encephalomyelitis, acrodermatitis chronica atrophicans (ACA), chronic arthritis.
Antibiotic therapy is indicated in all stages of the disease. It shortens disease duration significantly, when instituted in stage 1. Diagnosis of the bacterial infection relies on the detection of specific IgM antibodies against Borrelia.

To ensure diagnostic specificity, the Borrelia IgM ELISA microwell strips are coated with the following Borellia-specific recombinant antigens:

p21 = OspC (outer surface protein C): B. afzellii (pKo), B. garinii (20047)

p41/I = (inner part of flagellin): B. bavariensis (pBi)

VIsE: fusion proteins of different Borrelia genospecies

Many features of later infection are not specific to Lyme Borreliosis and occur in other conditions. The diagnosis of Lyme Borreliosis should be made only after careful evaluation of the patient´s clinical history, physical findings, laboratory evidence and exposure risk evaluation.
产品描述
Method Indirect ELISA, HRP/TMB, 12×8-well detachable strips Sample type Serum, plasma and CSF Sample volume 10 µl / sample (serum and plasma), 100 µl / sample (CSF) Assay time 1 h / 30 min / 15 min Standard range 0 – 30 BBU/ml (Biomedica Borrelia Units) Sensitivity 100% (serum) 82% (CSF) Cross-reactivity The assay works with human samples only. Specificity Endogenous and recombinant human anti-Borrelia IgM (B. burgdoreri ss, B. afzelii, B. garnii, B. bavariensis)
产品特点
保存建议
+4°C
其他
Biomedica Immunoassay(bmgrp)公司成立于1988年, 总部位于奥地利维也纳,主要致力于研究、开发和生产基于ELISA方法用于临床前研究相关标记物检测的工具。迄今为止Biomedica Immunoassay公司在心血管检测及骨代谢检测领域开发了一系列特色ELISA检测试剂盒,Biomedica Immunoassay的生产过程符合GMP/GLP指南,并符合ISO 9001:2015管理体系,有CE认证。Biomedica Immunoassay的产品根据FDA, EMEA和ICH指南进行验证,并具有验证报告。
注意
该页面的中文产品信息的翻译,仅供参考。准确的产品信息请以厂家的英文说明书为准。下单前,请浏览说明书确认。
在线留言
产品分类
特色产品 MORE
最近促销 MORE
  • 高品质保障 成熟的生产研发技术
  • 高性价比 价宜质优,性价比高
  • 高效省心 从购买到使用,放心无忧
  • 安全运输 完善的保护措施安全运输

微信扫码在线客服

微信咨询

全国免费技术支持

400-6800-868

在线客服